Abstract
Breast cancer is a highly prevalent disease and highly diversified, however, a part of these tumours present oestrogen receptor that as they are activated, induce tumour growth, becoming a target for treatment. Hormonotherapy decreases the level of oestrogen in women, either by competitive inhibition (tamoxifen) or by inhibition of peripheral conversion of oestrogen (anastrozole). Because…